Benjamin Enerson is listed as an executive officer on 8 SEC Form D filings by 3 issuers between Feb 2018 and Apr 2023: Finch Therapeutics Group, Inc. (Somerville, MA — biotechnology — 2018–2020; $90M reported sold to 43 investors), Tremeau Pharmaceuticals, Inc. (Cambridge, MA — pharmaceuticals — 2018; $5.2M reported sold to 59 investors) and Lennham Pharmaceuticals, Inc. (Concord, MA — pharmaceuticals — 2021–2023; $2.33M reported sold to 19 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer, over about 5 years. Across those companies the filings report $97.5M sold in total.
Listed alongside Andrew Mulderry (5 shared filings), Andrew Noh (5 shared filings), Chris Lange (5 shared filings), James Burgess (5 shared filings), Jeffery A. Smisek (5 shared filings) and 12 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Benjamin. Each name links to their own page.
1 of the issuers belongs to the sponsor group Finch Therapeutics (2 issuers, $93.7M reported sold, 2015–2020).
What this means A sponsor group is one team that sets up a new company for each deal. Finch Therapeutics has 2 companies on file and $93.7M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 13 court cases matching the name, 4 bankruptcy cases matching the name listed in Key records below.
What this means 17 records came back, including 2 court cases still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 8 public filings for Benjamin Enerson and found 5 differences, 3 worth asking the sponsor about: Form D filed 523 days after the first sale; Form D filed 486 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.